| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,439 |
12,463 |
$472K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,140 |
2,915 |
$225K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,318 |
3,633 |
$177K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,524 |
2,306 |
$172K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,931 |
1,776 |
$145K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,034 |
4,832 |
$116K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,235 |
1,090 |
$95K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,075 |
999 |
$55K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
420 |
290 |
$37K |
| 99381 |
|
600 |
534 |
$36K |
| 90461 |
|
4,468 |
3,331 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
987 |
454 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
659 |
604 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
224 |
200 |
$7K |
| 99383 |
|
87 |
70 |
$6K |
| 99000 |
|
670 |
614 |
$5K |
| 83655 |
|
552 |
454 |
$4K |
| 99384 |
|
51 |
46 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
87 |
66 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
103 |
89 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
13 |
$891.87 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
147 |
124 |
$751.69 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
38 |
38 |
$323.28 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
39 |
32 |
$306.06 |
| 85018 |
|
252 |
205 |
$169.39 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
14 |
$23.18 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
36 |
31 |
$16.01 |
| 96160 |
|
15 |
14 |
$4.50 |
| 90697 |
|
842 |
788 |
$1.12 |
| 90677 |
|
500 |
494 |
$0.63 |
| 90619 |
|
45 |
44 |
$0.11 |
| 90651 |
|
65 |
61 |
$0.01 |
| 90700 |
|
526 |
473 |
$0.00 |
| 90633 |
|
1,213 |
1,128 |
$0.00 |
| 90713 |
|
51 |
37 |
$0.00 |
| 90707 |
|
755 |
601 |
$0.00 |
| 90670 |
|
1,784 |
1,594 |
$0.00 |
| 90648 |
|
428 |
407 |
$0.00 |
| 90710 |
|
393 |
377 |
$0.00 |
| 3078F |
|
12 |
12 |
$0.00 |
| 90734 |
|
295 |
256 |
$0.00 |
| 90715 |
|
247 |
217 |
$0.00 |
| 90649 |
|
16 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,560 |
1,306 |
$0.00 |
| 90716 |
|
760 |
632 |
$0.00 |
| 90698 |
|
494 |
420 |
$0.00 |
| 90696 |
|
255 |
184 |
$0.00 |
| 90680 |
|
1,315 |
1,201 |
$0.00 |
| 90686 |
|
165 |
152 |
$0.00 |
| 90723 |
|
166 |
159 |
$0.00 |
| 90656 |
|
62 |
62 |
$0.00 |
| 96127 |
|
28 |
26 |
$0.00 |
| 90744 |
|
79 |
42 |
$0.00 |
| 3074F |
|
12 |
12 |
$0.00 |
| 0001A |
|
16 |
16 |
$0.00 |